Kukje Pharma Co., Ltd. (국제약품(주))
KOSPI Stock Code: 002720 | DART Corp Code: 00104722
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | Kukje Pharma Co., Ltd. |
|---|---|
| Korean legal name | 국제약품(주) |
| Alternate names | 국제약품 |
| Market | KOSPI |
| Stock Code | 002720 |
| DART Corp Code | 00104722 |
| CEO | 남태훈 |
| Business Registration No. | 2078100309 |
| Corporate Registration No. | 1101110032154 |
| Established Date | 1959-07-27 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 경기도 성남시 분당구 야탑로 96-8 |
| Homepage | https://www.kukjepharm.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000669 |
| verified_at | 2026-11-01T02:14:24.408Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000669
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 175,496,223,500 | KRW 156,462,822,664 |
| Operating Income (영업이익) | KRW 6,184,872,347 | KRW 6,701,642,414 |
| Net Income (당기순이익) | KRW 5,704,911,934 | KRW 5,206,078,928 |
| Total Assets (자산총계) | KRW 182,276,329,389 | KRW 165,547,573,574 |
| Total Liabilities (부채총계) | KRW 84,574,065,322 | KRW 75,999,396,198 |
| Total Equity (자본총계) | KRW 97,702,264,067 | KRW 89,548,177,376 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-08 | 20261008000513 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 남태훈 |
2026-10-08 | 20261008000507 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 남영우 |
2026-10-07 | 20261006000461 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 남영우 |
2026-10-06 | 20261006800768 | Change of the Largest Shareholder | 최대주주변경 | 국제약품 |
2026-10-06 | 20261006800666 | Report on Shares Change of Largest Shareholders(Change of the Largest Shareholders) | 최대주주등소유주식변동신고서(최대주주변경시) | 국제약품 |
2026-09-23 | 20260923800634 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 국제약품 |
2026-09-23 | 20260923000567 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 남영우 |
2026-09-04 | 20260904000350 | Report on trading plan of specific securities, etc. by executive officers and major shareholders | 임원ㆍ주요주주특정증권등거래계획보고서 | 남태훈 |
2026-09-04 | 20260904000347 | Report on trading plan of specific securities, etc. by executive officers and major shareholders | 임원ㆍ주요주주특정증권등거래계획보고서 | 남영우 |
2026-08-24 | 20260824800587 | New Facility Investment, etc. | 신규시설투자등 | 국제약품 |
2026-08-14 | 20260814002862 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 국제약품 |
2026-08-11 | 20260811000611 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 남영우 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000669 | verified_at: 2026-11-01T02:14:24.408Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.